# Therapeuticsmd (TXMD) — News

TXMD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/txmd/news

## Recent headlines

- [TherapeuticsMD 1Q EPS 1.0c](https://www.ainvest.com/news/therapeuticsmd-1q-eps-1-0c-2605) — AInvest Wire, May 12, 2026
  TherapeuticsMD, Inc. (NASDAQ: TXMD) reported a first-quarter 2025 net loss from continuing operations of $636,000, or $0.06 per basic and diluted common share, representing a decrease of $99,000 compared to the same period in 2024, when the company recorded a net loss of $809,000, or $0.07 per…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).